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Abstract 
California was the first state to legalize marijuana for medical purposes. Individuals are issued 
identification card for medical marijuana use for patients with chronic medical conditions if directed by a 
physician. Surveys have suggested there are regional differences between northern California residents, 
particularly the Bay Area, and southern California residents with respect to medical marijuana use and 
legalization. The purpose of this paper is to discuss the California Department of Public Health statistics 
regarding medical marijuana card registrations over various geographic areas of California. The 
California Department of Public Health Medical Marijuana Card Registration database reflects this with 
more individuals in the Bay Area registered compared to those in the ten southernmost counties of 
California. The reasons for this are unclear but could fall along political party lines as more registered 
Democrats support medical marijuana legalization compared to registered Republicans. The benefits of 
medical marijuana and potential adverse medical and socioeconomic effects have not been fully 
elucidated. Conclusion: There is a need for further study of the potential benefits for medical marijuana 
use and the reasons for apparent regional different beliefs of medical marijuana use and medical 
marijuana card registration. 
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Introduction 
 
Marijuana, Cannabis sativa, has been cultivated 
and utilized for thousands of years for 
recreational, spiritual, and medicinal purposes. 
There are several compounds in Cannabis 
sativa, for example, Δ9-tetrahydrocannabinol  
(THC), and cannabidiol. However, THC is the 
most commonly cited active compound (Maule, 
2015; Watson, Benson & Joy, 2000; Reinarman, 
Nunberg, Lanthier, & Heddleston, 2011). There 
is conflicting data about the medical benefits of 
marijuana (Reinarman, Nunberg, Lanthier, & 
Heddleston, 2011). Although the majority of 
studies focus on THC there are data identifying 
medicinal benefits of cannabidiol to prevent 
seizures (Reinarman, Nunberg, Lanthier, & 
Heddleston, 2011). Furthermore, cannabidiol 
does not have potent psychotropic properties of 
THC. (Szaflarski & Bebin, 2014). The two most 
common routes of administration of medical 
marijuana is smoking and ingesting foods 
containing THC and/or cannabidiol (Watson, 
Benson & Joy, 2000; Maccoun, & Mello, 2015).  
 
Medical Marijuana Cards 
Medical marijuana, as we now know it, came to 
the forefront in the early 1990s. California was 
the first state to legalize medical marijuana in 
1996 (Ryan-Ibarra, Induni, & Ewing, 2014).  
However, medical marijuana became legal to 
prescribe and use only in 2003, when the 
Medical Marijuana Protection Act was signed 
into California law, which established an 
identification card system for medical marijuana 
use. These medical marijuana cards were first 
issued in 2004 for patients with chronic illnesses 
if directed by a physician (Ryan-Ibarra, Induni, 
& Ewing, 2014). Currently, 23 states in the 
United States have legalized marijuana for 
medical purposes. Four states; Alaska, Colorado, 
Oregon, Washington and the District of 
Columbia have legalized marijuana for 
recreational use (Maule, 2015).  
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State versus Federal Legislation 
This legalization is at odds with the federal 
classification of marijuana as a Class I 
controlled substance with no medicinal benefits 
(USDOJ, 2009). However, in October 2009 U.S. 
Deputy Attorney General David W. Ogden 
issued a memo to address these competing 
legislations: “As a general matter, pursuit of 
these priorities should not focus federal 
resources in your States on individuals whose 
actions are in clear and unambiguous 
compliance with existing state laws providing 
for the medical use of marijuana. For example, 
prosecution of individuals with cancer or other 
serious illnesses who use marijuana as part of a 
recommended treatment regimen consistent with 
applicable state law, or those caregivers in clear 
and unambiguous compliance with existing state 
law who provide such individuals with 
marijuana is unlikely to be an efficient use of 
limited federal resources (USDOJ, 2009).”  
 
Medical Marijuana Use in California 
It is estimated that there are over 200,000 
medical marijuana users in California 
(Reinarman, Nunberg, Lanthier, & Heddleston, 
2011). In California, medical marijuana is sold 
from “dispensaries.” In California a “medical 
marijuana dispensary” is defined as: as any 
facility or location where medical marijuana is 
grown, made available to and/or distributed to, 
two or more of the following: primary 
caregivers, qualified patients, or individuals with 
identification cards (MMD, 2016). The exact 
number of dispensaries in California is 
unknown, but was estimated to be well over 
1,000 in 2009 (Warner, 2009). Regulation of 
dispensaries has been challenging and the City 
of Los Angeles has closed over 500 dispensaries 
for various infractions including operating too 
close to public parks, schools and other facilities 
(Reyes & Saillant, 2015).  
 
The medical reasons for marijuana use are wide 
and varied including: relief from insomnia, 
anxiety, muscle spasms, seizures, nausea and 
vomiting, depression, involuntary movements, 
and glaucoma, to improve appetite and mental 
focus (Nunberg, Kilmer, Pacula, & Burgdorf, 
2011; Reinarman, Nunberg, Lanthier, & 
Heddleston, 2011; Watson, Benson & Joy, 
2000). Interestingly, over half the patients report 
using medical marijuana as a substitute for 
prescription medication rather than as adjuvant 
agent (Reinarman, Nunberg, Lanthier, & 
Heddleston, 2011).  
 
California not only has diverse geographic 
regions (e.g., urban, rural, and suburban), but 
also diverse ethnic, religious and political 
groups. A telephone survey of 7,525 randomly 
selected adults in California found that five 
percent of the population sampled reported ever 
using marijuana for medical purposes. These 
authors found similar prevalence rates of 
medical marijuana use in northern California, 
southern California and the Bay Area, 6%, 4% 
and 4%, respectively (Ryan-Ibarra, Induni, & 
Ewing, 2014). However, a newspaper poll found 
a majority of Bay Area residents, 55%, favored 
the legalization of marijuana compared to only 
41% of southern California residents (Mozingo, 
2012).  
 
A study identified the locations of medical 
marijuana dispensaries in California being 
predominantly found in lower income areas and 
unincorporated areas, with close proximity to 
establishments selling alcoholic beverages 
(Morrison, Gruenewald, Freisthler, Ponicki, & 
Remer, 2014). The authors theorized that the 
communities in such areas lack the resources to 
resist the establishment of dispensaries, 
compared to communities located in higher 
income and incorporated areas. Interestingly, 
another study showed 50.9 % of their survey 
participants had at least some college or were 
college graduates; 64.8 % of the respondents 
were employed and 73.4% had health insurance 
(Reinarman, Nunberg, Lanthier, & Heddleston, 
2011) . This seems to offer that MMIC holders 
travel to lower income areas to obtain medical 
marijuana from dispensaries whilst themselves 
being more educated and with higher incomes. 
This could reflect less access to physicians in 
lower income groups to approve MMIC.     
 
We queried the publicly available California 
Department of Public Health’s Medical 
Marijuana Program (MMP) registry database 
(CDPH, 2014). This database was specifically 
established to create a repository of State-
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authorized medical marijuana identification card 
(MMIC) issuances. The CDPH MMP was 
specifically established to create a State-
authorized medical marijuana identification 
card, along with a registry database for 
verification of qualified patients and their 
primary caregivers. Participation by patients and 
primary caregivers in this identification card 
program is voluntary. The MMP Web-based 
registry allows law enforcement and the public 
to verify the validity of a qualified patient or 
primary caregiver's MMIC as authorization to 
possess, grow, transport, and/or use medical 
marijuana within California (CDPH, 2015). 
 
The CDPH MMP lists MMIC registration by 
fiscal year and county only, however, does not 
group together in geographic regions. We 
evaluated two representative years, 2005 the 
year following MMIC implementation, and 
2012, eight years after implementation and 
grouped by geographic regions. In the fiscal year 
2005 there was a large discrepancy between 
geographic regions of medical marijuana card 
registration. For northern California, defined as 
the 48 northernmost counties, there were 9.3 
MMIC per 100,000 residents compared to 2 
MMIC per 100,000 for the 10 southernmost 
counties. There was less disagreement in fiscal 
year 2012, where northern California had 15.4 
MMIC per 100,000 compared to 13.1 MMIC per 
100,000 for southern California. However, 
selecting out the 8 Bay Area counties shows a 
larger penetrance of MMIC registration, 40.4 per 
100,000 and 30.2 per 100,000 in fiscal years 
2005 and 2012, respectively (CDPH, 2014).  
 
Potential Reasons for Geographic Differences 
in Medicinal Marijuana Use 
The reasons for geographic differences are 
unclear but possibly originate from different 
regional feelings and beliefs regarding marijuana 
use for medical purposes. This could also follow 
along political party lines, as the Bay Area has 
the largest amount of registered Democratic 
voters in California compared to southern 
California, which has a more even distribution 
of both Democratic and Republican registered 
voters (PPIC, 2014). Democratic voters in 
general support the legalization of marijuana 
compared to Republican voters (Mozingo, 
2012). However, there are other potential 
differences for the discrepancies seen in the 
geographic areas. Finally, participation in the 
MMP database is voluntary and higher numbers 
reflected in our data could represent increased 
compliance with registering in certain 
geographic regions compared to others.  
 
There are several social and cultural concerns 
with the legalization of marijuana for medical 
purposes in California. In one study, several 
patients who utilize medical marijuana report 
being stigmatized as abusers or “stoners” by 
friends and family rather than being accepted as 
using to treat a medical condition (Satterlund, 
Lee, & Moore, 2015). In addition, these patients 
report not telling their regular physicians of 
medicinal marijuana use and seeking 
prescriptions from other physicians (Satterlund, 
Lee, & Moore, 2015). This is concerning as 
patients may manifest clinical effects or adverse 
effects from medical marijuana that may be 
attributed to a potential disease state by their 
physicians if they are unaware of medical 
marijuana use.  
 
Conclusion 
 
As more states legalize marijuana for medical 
use there continues to be a need for well-
controlled randomized double-blind studies to 
accurately assess true medical benefits. A study 
showed cannabis-involved driving had increased 
in California since 2007 in randomly selected 
drivers and were more likely to be MMIC 
holders (Johnson, Kelley-Baker, Voas, & Lacey, 
2012). Driving under the influence of THC has 
been shown to impair ability to drive safely 
(O'Kane, Tutt, & Bauer, 2002). Therefore, there 
is a need to continue to study this concerning 
trend.  
 
Our data suggests there may be major social and 
political ramifications of the variation we 
identified between northern California and 
southern California. This raises the question: Do 
individuals who support both the use and 
legalization of medical marijuana relocate to 
areas where there is higher use and support of 
medical marijuana, for example, the Bay Area? 
This variation could have larger political 
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repercussions, with an imbalance or 
preponderance of one political party over 
another in various geographic regions of 
California. Federal legislation on medical 
marijuana and statewide dispensary regulations 
may obviate the current local differences in 
medical marijuana use and regulation. 
 
Furthermore, as stated in the Institute of 
Medicine study, smoking marijuana is an 
“ineffective delivery device,” meaning there is 
wide variation of dose delivered by smoking. 
The Institute of Medicine also cautions that 
smoking marijuana may result in harmful side 
effects from smoke (Watson, Benson & Joy, 
2000). In addition, marijuana edibles have 
varying concentrations of THC and rate of 
absorption from the gastrointestinal tract 
(Maccoun, & Mello, 2015). As such, the 
potential beneficial compounds in marijuana 
medical applications should be identified and 
isolated to allow for more precise dosing and 
administration through controlled trials and the 
rigors of the peer-review process to further 
elucidate the role of medical marijuana in the 
treatment of patients.  
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